SLC25A22: A Potential Drug Target and Biomarker (G79751)

Target Name: SLC25A22

NCBI ID: G79751

SLC25A22

SLC25A22: A Potential Drug Target and Biomarker

SLC25A22 is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, diabetes, and neurological disorders. The SLC25A22 gene is located on chromosome 16 and encodes a protein known as SLC25A22, which is a zinc transporter.

SLC25A22 has been shown to be expressed in a variety of tissues and cells, including the brain, pancreas, and testes. It has also been shown to be involved in the regulation of various cellular processes, including cell signaling, DNA replication, and metabolism.

One of the most promising aspects of SLC25A22 is its potential as a drug target. SLC25A22 has been shown to be involved in the regulation of various signaling pathways, including the TGF-β pathway, which is involved in the development and progression of many diseases, including cancer.

In addition, SLC25A22 has also been shown to be involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of various cellular processes, including cell signaling, migration, and invasion.

SLC25A22 has also been shown to be involved in the regulation of the NF-kappa-B signaling pathway, which is involved in the regulation of various cellular processes, including inflammation and stress responses.

In addition to its potential as a drug target, SLC25A22 has also been shown to be a potential biomarker for various diseases, including cancer. Several studies have shown that SLC25A22 is often decreased in various types of cancer, including breast, ovarian, and prostate cancer.

In addition, SLC25A22 has also been shown to be involved in the regulation of cellular processes that are important for maintaining cellular homeostasis, including the regulation of ion channels and the regulation of pH.

Overall, SLC25A22 is a gene that has great potential as a drug target or biomarker for various diseases. Further research is needed to fully understand the role of SLC25A22 in these processes and to develop safe and effective treatments for these diseases.

Protein Name: Solute Carrier Family 25 Member 22

Functions: Mitochondrial glutamate/H(+) symporter. Responsible for the transport of glutamate from the cytosol into the mitochondrial matrix with the concomitant import of a proton (PubMed:11897791). Plays a role in the control of glucose-stimulated insulin secretion (By similarity)

The "SLC25A22 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC25A22 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets